Today: 14 May 2026

Khadija Saeed

A dedicated markets reporter, she covers stocks, macroeconomics, and major business developments with a sharp eye for detail and accuracy.

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s (KSS) Stock Today, November 25, 2025: New CEO, Q3 Earnings on Deck and a Big Holiday Test

Kohl’s named Michael J. Bender as permanent CEO on November 24, making him the fourth chief since 2018. Shares traded near $15.70 early Tuesday, valuing the company at about $1.8 billion, ahead of third-quarter earnings expected to show a loss and declining sales. Short interest stands at roughly 26–27% of float. The board declared a $0.125 per share dividend, payable December 24.
25 November 2025
··
Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell Stock (DELL) Today: AI Server Boom Meets Margin Jitters Ahead of Q3 Earnings – November 25, 2025

Dell shares closed Monday at $127.22, up 3.8%, but remain down nearly 20% for the month and about 24% below their early-November high. Wall Street expects Q3 revenue near $27.2 billion and non-GAAP EPS around $2.48. Options imply a 9% post-earnings move. Project Maverick, Dell’s internal overhaul, faces a three-month delay due to scalability issues.
25 November 2025
····
VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

VKTX Stock Today, November 25, 2025: Can Viking Therapeutics Keep Riding the Obesity Drug Wave?

Viking Therapeutics closed at $34.65 on November 24, valuing the company at about $3.9 billion. The firm completed enrollment in its Phase 3 obesity trial VANQUISH-1 ahead of schedule, with its lead drug VK2735 now in late-stage testing. Shares remain volatile, trading far below their 52-week high of $56.25 but well above the low of $18.92. Viking has no approved products or product revenue.
25 November 2025
··
Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer (PFE) Stock Today: Near‑7% Dividend Yield, Obesity Bet and Pipeline Shift Take Center Stage – November 25, 2025

Pfizer shares traded near $25 late Monday, valuing the company at about $143 billion, with a dividend yield of roughly 6.8%. Q3 2025 revenue fell 6% to $16.7 billion, as COVID product sales declined sharply, but non-COVID portfolio sales rose 4%. Adjusted EPS of $0.87 beat expectations by over 30%. Pfizer reaffirmed 2025 revenue guidance and raised its adjusted EPS outlook.
25 November 2025
·
TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

TNXP Stock Today (Nov. 25, 2025): Tonix Slips as Wall Street Weighs MDD IND Win, Tonmya Launch, and Dilution Risk

Tonix Pharmaceuticals shares fell 11% to close at $14.29 on Monday, despite receiving FDA clearance to advance its depression drug TNX-102 SL into Phase 2 trials. The stock sits near the bottom of its 52-week range after sharp volatility and recent expansion of its at-the-market stock offering program. Tonix recently launched Tonmya for fibromyalgia and reported $190.1 million in cash for Q3 2025.
25 November 2025
·
Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu (BIDU) Stock Today, November 2525, 2025: JP Morgan Upgrade Sparks 7% Rally After Mixed Q3 Earnings

Baidu shares jumped 7.5% to $119 on November 25 after JP Morgan upgraded the stock to “Overweight” and raised its price target to $188. The rally followed a mixed Q3 report showing revenue fell 7% to RMB 31.2 billion, with continued growth in AI and cloud offsetting weakness in advertising. Institutional investors, including Sierra Summit Advisors, increased positions in recent months.
25 November 2025
··
Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy (BBY) Stock Today, Nov. 25, 2025: Price, 5% Yield and What to Watch Before Earnings

Best Buy shares fell 1.1% to $75.62 Monday, underperforming major indexes, with trading volume spiking to nearly 7 million shares ahead of Tuesday’s earnings report. Wall Street expects Q3 EPS of $1.31 on $9.6 billion revenue. The stock yields about 5% and trades at 21 times trailing earnings. Holiday sales forecasts remain weak, and tariffs continue to pressure margins.
25 November 2025
·
Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics (PNG.V) Edges Higher After Record Q3 2025 Earnings and Strong 2025 Outlook – Stock Update for November 24, 2025

Kraken Robotics shares closed at C$5.39 on November 24, up C$0.03, after reporting record Q3 revenue of C$31.3 million, a 60% year-over-year increase. Trading volume surged to 2.87 million shares, well above average. Gross profit rose 81% to C$18.6 million, with gross margin improving to 59%. The company reaffirmed its full-year outlook.
25 November 2025
··
MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

MPW Stock Today (November 24, 2025): Dividend Hike, Buyback and Short Interest Drive Medical Properties Trust’s Turnaround Story

Medical Properties Trust (NYSE: MPW) closed Monday at about $5.31 per share, little changed after announcing a 12.5% dividend increase and a $150 million buyback. The REIT’s stock is up 25% over the past year but remains down more than 50% from three years ago. Average volume slightly exceeded normal at 8.6 million shares. Market cap stands near $3.2 billion.
24 November 2025
···
BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

BFLY Stock Today: Butterfly Network Jumps on Licensing Deal, Insider Buying and AI Momentum (Nov. 24, 2025)

Butterfly Network shares jumped about 24% to $3.28–$3.29 Monday after announcing a five-year, $25 million-plus licensing deal with Midjourney for its ultrasound-on-chip technology. Trading volume topped 16 million shares. The stock’s market cap stands near $800 million, with shares swinging between $1.32 and $4.98 over the past year.
24 November 2025
···
MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

MOH Stock Today, Nov. 24, 2025: Molina Healthcare Rallies on ACA Subsidy Hopes as Lawsuits and Margin Pressures Linger

Molina Healthcare shares closed up 2.6% at $145.30 Monday on heavy volume after reports of a possible extension of ACA subsidies. The stock remains down over 50% from its 52-week high following an October earnings shock and ongoing class-action lawsuits. Market cap stood at $7.5 billion, with a P/E ratio near 9x. Intraday trading ranged from $141 to $151.
24 November 2025
·
CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

CLSD Stock Crashes Over 60% Today as Clearside Biomedical Files for Chapter 11 Bankruptcy

Clearside Biomedical filed for Chapter 11 bankruptcy Monday and will seek a court-supervised sale of its assets. CLSD stock plunged nearly 68% to around $0.88 by late afternoon, hitting a new 52-week low after closing at $2.69 Friday. Trading volume spiked to roughly 12 times normal levels. The company cited “substantial doubt” about its ability to continue as a going concern in its latest quarterly filing.
24 November 2025
··
GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

GPUS Stock Today, November 24, 2025: Hyperscale Data Jumps After Joining Top 100 Bitcoin Treasuries – Price, News and Outlook

Hyperscale Data Inc. (NYSE American: GPUS) shares rose about 12% to $0.28 Monday after the company announced it joined the global top 100 public Bitcoin treasury companies. Trading volume reached 30 million shares by mid-afternoon. GPUS stock remains down over 95% from its 52-week high near $10. The company now holds roughly 382 Bitcoin, up from 150 earlier this year.
24 November 2025
···
1 … 800 801 802 803 804 … 808

Stock Market Today

  • NGEx Minerals Shares Surge 12.7% on Lunahuasi Drilling Results and Adit Approval
    May 13, 2026, 8:06 PM EDT. NGEx Minerals (TSX:NGEX) shares rose 12.7% after announcing completion of its Phase 4 drilling program at the Lunahuasi copper-gold-silver project in Argentina, featuring high-grade intersections. The company also secured environmental approval for an underground exploration adit, expanding future drilling and sampling options. These developments support the investment narrative that hinges on assay results shaping the potential scale of deposits at Mars, Saturn, Jupiter, and new zones. Despite the positive news, investor caution remains due to ongoing losses, funding needs, and risks that drill results may not translate into an economic mine. Shares remain volatile with a wide valuation range among analysts, reflecting differing views on exploration success and project risk.

Latest articles

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

Enovix Stock Drops After Q1 Beat as Smartphone Battery Tests Stay Unfinished

14 May 2026
Enovix shares dropped 12.9% to $6.35 after hours Wednesday despite beating first-quarter revenue and adjusted-loss estimates. The decline followed news that smartphone battery qualification remains unfinished, with the company passing 72 of 75 customer tests. Revenue rose 49% to $7.6 million. Enovix cited progress in defense, industrial, and smart-eyewear sales.
Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

Lightwave Logic Stock Jumps as AI-Photonics Bet Heads for a 2027 Production Test

14 May 2026
Lightwave Logic reported Q1 revenue up 27% to $29,000 and a net loss widening to $6.3 million. Shares rose 14% after the company said it is negotiating a supply and licensing deal for high-volume production in 2027. Four Fortune 500 customers are now in Stage 3 prototyping. Cash and equivalents totaled about $100 million as of May 11.
USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

USA Rare Earth Stock Watch: Q1 Revenue, $1.75 Billion Cash and the China Supply Crunch

14 May 2026
USA Rare Earth reported Q1 revenue of $5.7 million and a net loss of $67 million, ending March with $1.75 billion in cash after a $1.5 billion PIPE. The company expects to sign documents this month for $1.6 billion in U.S. Commerce Department funding. Texas awarded a $14.18 million grant for the Round Top project. USA Rare Earth agreed in April to acquire Brazil’s Serra Verde for $2.8 billion.
Go toTop